STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

18.12.2013 18:14

Dissemination of a Voting Rights Announcement, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Correction of the voting rights notification dated December 13, 2013
Montanaro Asset Management Limited, London, UK, notified us on December 10, 2013 pursuant to section 21 (1) of the German Securities Trading Act (WpHG), that its share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001, fell below the threshold of 5% on December 5, 2013 and amounted to 4.78% of all voting rights on that date, corresponding to 562,565 voting rights. 4.78% of voting rights (562,565 voting rights) are attributable to Montanaro Asset Management Limited pursuant to section 22 (1) sentence 1 number 6 of the German Securities Trading Act (WpHG).

The voting rights attributable to Montanaro Asset Management Limited were held via the following shareholder whose share of voting rights in STRATEC Biomedical AG amounted to 3% or more: Montanaro European Smaller Companies PLC.

18.12.2013 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at and

Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
End of Announcement DGAP News-Service